SEC 8-K
SEC 8-K: Item 1.01, 2.03, 9.01
Official SEC filing update. Items: 1.01, 2.03, 9.01.
Item 1.01, 2.03, 9.01Accession 0000785161-26-000161
Encompass Health (EHC) Financials, Dividends & Stock Info
Explore comprehensive financial data for Encompass Health, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
EHCHealth Care
Encompass Health (EHC) is a health care facilities company.
Encompass Health Financial Health ScoreFY2025
0/100
Moderate health; several metrics need attention
+3 pts YoYProfitability63Liquidity55Growth80Cash Flow65Efficiency75
This Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Encompass Health Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 8-K
SEC 8-K: Item 1.01, 8.01, 9.01
Official SEC filing update. Items: 1.01, 8.01, 9.01.
Item 1.01, 8.01, 9.01Accession 0000785161-26-000156
SEC 8-K
SEC 8-K: Item 5.07
Official SEC filing update. Items: 5.07.
Item 5.07Accession 0000785161-26-000151
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0000785161-26-000130
SEC 8-K
SEC 8-K: Item 2.02, 7.01, 9.01
Official SEC filing update. Items: 2.02, 7.01, 9.01.
Item 2.02, 7.01, 9.01Accession 0000785161-26-000128
Source: SEC EDGAR · 5 filings
Informational only. Not investment advice.
Encompass Health Recent Events
Material Agreement
Material Agreement
Other Events
Shareholder Vote
Earnings Results
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Revenue Breakdown (FY2024)
See Encompass Health detailed breakdown →Inpatient
$5.2B97.3%
OutpatientAndOther
$143M2.7%
About Encompass Health
Encompass Health Corporation, based in Birmingham, Alabama, is the nation's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 166 inpatient rehabilitation hospitals located in 38 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.
- Industry
- Health Care Facilities
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Profitability Data Under ReviewProfitability metrics are being verified. Some SEC filing data may require additional validation.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Encompass Health 10-Year Revenue, Profit & Cash Flow History
Net income reached a record high of $566M in FY2025.
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B(+10.5%) | $5.4B(+33.8%) | $4.0B(-7.7%) | $4.3B(+8.3%) | $4.0B(+12.6%) | $3.6B(-8.9%) | $3.9B(+7.4%) | $3.6B(-6.9%) | $3.9B(+7.4%) | $3.6B |
| Net Income | $566.2M(+24.2%) | $455.7M(+10.6%) | $412.2M(+52.1%) | $271.0M(-34.3%) | $412.2M(+45.0%) | $284.2M(+4.8%) | $271.1M(+9.5%) | $247.6M(-8.7%) | $271.1M(+9.5%) | $247.6M(+35.2%) |
| Total Assets | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B | $6.4B | $6.1B | $5.2B | $4.9B | $4.7B |
| Total Debt | - | - | - | - | - | - | - | - | - | - |
| Total Equity | $2.4B | $2.1B | $1.6B | $1.3B | $1.9B | $1.6B | $1.4B | $1.3B | $1.4B | $910.6M |
| Profit Margin | 9.5% | 8.5% | 10.3% | 6.2% | 10.3% | 8.0% | 6.9% | 6.8% | 6.9% | 6.8% |
| ROE | 23.2% | 22.1% | 25.0% | 20.7% | 21.6% | 17.9% | 20.1% | 19.4% | 19.4% | 27.2% |
| ROA | 8.0% | 7.0% | 6.8% | 4.8% | 6.0% | 4.4% | 4.5% | 4.8% | 5.6% | 5.3% |
Quarterly Financials
Last 8 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.5B | $1.5B | $1.4B | $1.3B | $1.3B | $1.2B |
| Net Income | $151.5M | $126.5M | $142.1M | $151.5M | $108.2M | $114.1M | $112.5M | $85.3M |
| Total Assets | $7.1B | $6.9B | $6.8B | $6.6B | $6.5B | $6.4B | $6.2B | $6.0B |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Insider Trading
Loading chart...
Loading transactions...
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Encompass Health Dividend Safety Analysis & Growth History
Dividend Status
Dividend PayerCAGR (5Y)
-13.9%
CAGR (10Y)
-4.9%
This company pays dividends. Historical dividend data shown below.
5-year dividend CAGR: -13.9%.
Annual Dividends
2016 - 2025| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $0.94 | $0.98 | $1.04 | $1.10 | $1.12 | $1.12 | $0.86 | $0.60 | $0.64 | $0.53 |
| YoY Growth | +6.8% | +4.3% | +6.1% | +5.8% | +1.8% | +0.0% | -23.2% | -30.2% | +6.7% | -17.2% |
| Payments | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Increased | Yes | Yes | Yes | Yes | Yes | No | No | No | Yes | No |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Encompass Health Free Cash Flow & Dividend Coverage
Free Cash Flow
$439.2M
FY2025
FCF Margin
7.4%
FCF / Revenue
Operating Cash Flow
$1.2B
Cash from operations
FCF / Net Income
0.78x
Below earnings
Generates approximately $1M in free cash flow per day.
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $640.2M | $658.3M | $640.2M | $658.3M | $704.7M | $715.8M | $705.8M | $715.8M | $1.0B | $1.2B |
| CapEx | -$177.7M | -$225.8M | -$177.7M | -$225.8M | -$392.8M | -$524.6M | -$564.8M | -$545.7M | -$642.5M | -$736.4M |
| Free Cash Flow | $462.5M | $432.5M | $462.5M | $432.5M | $311.9M | $191.2M | $141.0M | $170.1M | $360.3M | $439.2M |
| FCF Margin | 12.7% | 11.1% | 12.7% | 11.1% | 8.8% | 4.8% | 3.2% | 4.2% | 6.7% | 7.4% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Encompass Health Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Health Care. This is not a Billiver risk assessment for EHC.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Encompass Health FAQ
Does Encompass Health pay dividends?
Yes, Encompass Health pays regular dividends. View the full dividend history and payout analysis on this page.
What is Encompass Health's financial health score?
Encompass Health has a financial health score of 67/100 (Grade: C), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Encompass Health financial data are available?
10 years of financial data are available for Encompass Health from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.